Nesina (alogliptin) / AbbVie, Takeda  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nesina (alogliptin) / Takeda
NCT01664624: Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Completed
1b
40
US
Roflumilast, Daxas, Daliresp, Alogliptin, Nesina, Exenatide, Byetta, Bydureon, Placebo to roflumilast, Placebo to alogliptin
AstraZeneca
Type 2 Diabetes
11/12
11/12
NCT01391663: Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Completed
1
48
RoW
Alogliptin, SYR-322
Takeda
Pharmacokinetics and Pharmacodynamics
09/11
09/11
NCT00957268 / 2009-011221-13: Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Completed
1
46
US
Alogliptin, SYR-322
Takeda
Diabetes Mellitus, Type 2
11/13
11/13
NCT03501277: A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants

Completed
1
72
RoW
Alogliptin, Pioglitazone, SYR-322-4833 BL, Incresync
Takeda
Healthy Volunteers
07/18
07/18

Download Options